Cas:66309-69-1 Cefotiam hydrochloride manufacturer & supplier

Chemical Name:Cefotiam hydrochloride

CAS.NO:66309-69-1

Synonyms:MFCD00865087;(6R,7R)-7-(2-(2-Amino-4-thiazolyl)acetamido)-3-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Dihydrochloride;(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid dihydrochloride;CGP 14221/E;Cefotiam HCL;Cefotiam hydrochloride;EINECS 266-312-6;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[2-(2-amino-4-thiazolyl)acetyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl]thio]methyl]-8-oxo-, (6R,7R)-, hydrochloride (1:2);Cefotiam (hydrochloride)

Molecular Formula:C₁₈H₂₅Cl₂N₉O₄S₃

Molecular Weight:598.550

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:940ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:251.30000

Exact Mass:597.056885

LogP:1.05880

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like MFCD00865087 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cefotiam (hydrochloride) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cefotiam (hydrochloride) Use and application,Cefotiam hydrochloride technical grade,usp/ep/jp grade.

Related News: ��The number of confirmed cases of coronavirus in Taiwan is not higher than in most countries affected,�� Mr. Wu said. ��Other than China, no other country, no other country has had its flight banned by Italy.�� Cefotiam hydrochloride manufacturer This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.? Cefotiam hydrochloride supplier Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release. Cefotiam hydrochloride vendor The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development. Cefotiam hydrochloride factory The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development.